Fifty years of cervical and breast screening for one invented woman, each interval dated to its source: that is the timeline this NU576 schedule paper lays out, disagreements included. Searches like "nu 576 unit 3 assignment example", "nu576 unit 3 sample" and "nu576 unit 3 example" land here.
What a finished NU576 Unit 3 screening schedule paper looks like
A schedule table fills most of the three or four pages, its rows ages and its columns cervical screening, breast screening, the source behind each entry and the year of that source. At [24], cytology every three years follows the 2018 USPSTF statement, while the American Cancer Society's 2020 update would instead begin primary HPV testing at [25]. From [30], primary HPV testing every five years applies. An HPV-positive result with normal cytology at [38] triggers the 2019 ASCCP risk-based management guidelines: a repeat test in one year, then three years, then a return to five. Breast rows begin at [40] with biennial mammography under the 2024 USPSTF statement, and a dense-breast notice on one report is explained under the FDA rule effective September 2024. Cervical screening stops at [65] after adequate negative results.
How a NU576 Unit 3 example is structured
An opening paragraph states the patient's relevant history in four lines: average risk, vaccination status, no prior abnormal results and a mother with no breast cancer. The schedule table follows and carries the argument. Below it, one short section per decision point explains the entry. The first reconciles the USPSTF and ACS starting ages and states which one the paper follows and why. The second shows how the ASCCP guidelines replace the routine interval with a risk estimate after the abnormal result. The third addresses dense breasts, noting that supplemental imaging received an I statement in 2024 and is discussed, not ordered by default. The fourth defines adequate prior screening before the paper stops cervical testing at [65]. Closing the paper, one paragraph lists what would move her onto a different schedule, such as a new family history.
Two starting ages, one choice
The paper sets the USPSTF and ACS recommendations side by side and follows one of them, stating the reason. Leaving both in the table unresolved would give the patient no schedule at all.
A result that resets the clock
After the HPV-positive result, the routine five-year interval yields to a one-year return based on estimated risk. The paper shows each subsequent interval, the result that permits it and the path back to routine screening.
What the density notice means
Since September 2024, mammography reports have had to tell patients whether their breast tissue is dense. What that sentence implies for her risk is spelled out, and the discussion of supplemental imaging is recorded without an order.
Stopping at sixty-five, with conditions
Cervical screening ends only after adequate prior negative results, defined in the paper by number and recency. Without that record the schedule would continue, and the paper says so.
Triggers for a different schedule
A first-degree relative with breast cancer, a new abnormal cervical result or a hysterectomy are listed with the schedule each would bring. These entries show that the table describes average risk and nothing more.
Where marks go in NU576 Unit 3
Most grading checks each row of the schedule twice: is the interval right for the age in that row, and does it carry a named source with its year? Outdated intervals are the familiar deduction: annual cytology, cotesting presented as the only option after thirty, or mammography every year cited to a body that recommends two. Rubrics also check handling of the abnormal result, and a paper that keeps the five-year interval after an HPV-positive test has missed the unit's hardest step. Disagreement between guidelines is expected to be resolved in writing, not left in the table as two answers. Smaller losses come from stopping cervical screening at [65] without defining adequate prior screening, and from treating the density notice as a diagnosis when it is a risk statement.
Get a NU576 Unit 3 example written to your instructions
Screening prompts in NU576 name different ages and histories, so send the case exactly as written, plus the rubric used to grade it. Expect a schedule table with every interval dated and sourced, any abnormal result managed under current risk-based guidance, and conflicts between recommending bodies settled in prose. Your first paper costs nothing and reaches you within 24-48h.
NU576 Unit 3 questions, answered
Which cervical screening recommendation should the paper follow?
Whichever your course names, and many sections accept either the USPSTF or the American Cancer Society if the choice is stated and justified. The two differ mainly in starting age and preferred test. What costs marks is mixing them without comment, or citing one body for an interval it does not recommend.
Does HPV vaccination change the screening schedule?
Not under current US recommendations. Vaccinated and unvaccinated patients follow the same schedule, because vaccines do not cover every high-risk type and many adults were vaccinated after exposure. A paper can note vaccination status in the history, but the intervals in the table should not change because of it.
How should an abnormal result appear in a schedule paper?
As a break in the routine table, with the management guideline named. The ASCCP 2019 guidelines assign follow-up by estimated risk, so the paper should state the result, the recommended next step and interval, and what result would return the patient to routine screening. A single sentence saying follow up as indicated rarely earns credit.